AustinPx
Dave A. Miller, Ph.D. is currently the Chief Scientific Officer at AustinPx, bringing extensive experience in various roles in the pharmaceutical and manufacturing industry. Prior to this, Dave A. served as Vice President of Research and Development at DisperSol Technologies, and held senior scientist positions at Hoffmann-La Roche. With a Ph.D. in Pharmaceutics from The University of Texas at Austin, Dave has a strong academic background complemented by practical experience in roles such as Process Engineer at Celanese and Research Intern at PharmaForm.
AustinPx
AustinPx™, Pharmaceutics and Manufacturing, was founded to help developers realize the full potential of their drug candidates. There are many obstacles to bringing a drug to market, including poor bioavailability and accelerated timelines. That’s where we come in. Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges and identify opportunities to do more, faster. As the inventors of the KinetiSol® Technology - a next generation amorphous solid dispersion (ASD) technology for poorly soluble APIs - we look to disrupt the ASD industry with its smaller footprint, broader design space, and greener processing solution.